\-\ Texto\\:\\ \ \(0\)\
\-\ large\\,\\ soft\\ mass\\ on\\ left\\ thigh\ \(1\)\
\-\ wide\\ excision\\ with\\ xrt\\ and\\ chemotherapy\\.\ \(0\)\
\-\ f\\/u\\ mr\\ at\\ 6\\ months\\ was\\ negative\\ for\\ recurrence\\.\ \(0\)\
\-\ heterogenous\\ mass\\ in\\ the\\ posterior\\ thigh\\ with\\ some\\ fat\\ signal\\ \\(bright\\ on\\ t1\\)\\ along\\ with\\ low\\ t1\\ signal\\ region\\ consistent\\ with\\ cystic\\ component\\.\\ \\ some\\ areas\\ of\\ enhancement\\.\ \(0\)\
\-\ myxoid\\ liposarcoma\ \(4\)\
\-\ imaging\\ characteristics\\ consistent\\ with\\ myxoid\\ liposarcoma\\,\\ however\\ other\\ entities\\ that\\ could\\ be\\ in\\ the\\ differential\\ if\\ the\\ characteristics\\ were\\ a\\ little\\ different\\ include\\:\ \(1\)\
\-\ malignant\\ fibrous\\ histiocytoma\ \(11\)\
\-\ hemangioma\ \(165\)\
\-\ leiomyosarcoma\ \(24\)\
\-\ patient\\ presents\\ with\\ a\\ slow\\ growing\\ painless\\ mass\\ on\\ his\\ left\\ thigh\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ thigh\\:\\ 0\\.3841042993290478\ \(0\)\
\-\ myxoid\\:\\ 0\\.32752085000772224\ \(0\)\
\-\ liposarcoma\\:\\ 0\\.27848293311030853\ \(0\)\
\-\ characteristics\\:\\ 0\\.23871482726510418\ \(0\)\
\-\ some\\:\\ 0\\.16379809436956028\ \(0\)\
\-\ t1\\:\\ 0\\.16220284298472765\ \(0\)\
\-\ entities\\:\\ 0\\.15562159002257422\ \(0\)\
\-\ with\\:\\ 0\\.15292853469701242\ \(0\)\
\-\ histiocytoma\\:\\ 0\\.15052975900907686\ \(0\)\
\-\ xrt\\:\\ 0\\.1496347959127687\ \(0\)\
\-\ mass\\:\\ 0\\.14915957163338167\ \(0\)\
\-\ signal\\:\\ 0\\.14757457185397121\ \(0\)\
\-\ leiomyosarcoma\\:\\ 0\\.14714301724291884\ \(0\)\
\-\ consistent\\:\\ 0\\.1411577595046464\ \(0\)\
\-\ little\\:\\ 0\\.12803476644301595\ \(0\)\
\-\ growing\\:\\ 0\\.12769670642369602\ \(0\)\
\-\ wide\\:\\ 0\\.1260776847331411\ \(0\)\
\-\ slow\\:\\ 0\\.1254609273520386\ \(0\)\
\-\ heterogenous\\:\\ 0\\.12260487541019864\ \(0\)\
\-\ painless\\:\\ 0\\.12055237952424386\ \(0\)\
\-\ different\\:\\ 0\\.11912575038449236\ \(0\)\
\-\ bright\\:\\ 0\\.11866936249235811\ \(0\)\
\-\ on\\:\\ 0\\.11793690908099017\ \(0\)\
\-\ component\\:\\ 0\\.1115469099840426\ \(0\)\
\-\ hemangioma\\:\\ 0\\.1094926361843435\ \(0\)\
\-\ recurrence\\:\\ 0\\.10746940746863426\ \(0\)\
\-\ excision\\:\\ 0\\.10262787476665773\ \(0\)\
\-\ fibrous\\:\\ 0\\.10111328636566634\ \(0\)\
\-\ could\\:\\ 0\\.09467999181132039\ \(0\)\
\-\ malignant\\:\\ 0\\.09278681423256543\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.09242632278661811\ \(0\)\
\-\ left\\:\\ 0\\.08880478019318948\ \(0\)\
\-\ areas\\:\\ 0\\.08837354463534396\ \(0\)\
\-\ along\\:\\ 0\\.08720609649503538\ \(0\)\
\-\ differential\\:\\ 0\\.0845754239153008\ \(0\)\
\-\ mr\\:\\ 0\\.08422319986001885\ \(0\)\
\-\ fat\\:\\ 0\\.08097115300950751\ \(0\)\
\-\ negative\\:\\ 0\\.08058475110391743\ \(0\)\
\-\ his\\:\\ 0\\.07894241416259605\ \(0\)\
\-\ cystic\\:\\ 0\\.07839442749338685\ \(0\)\
\-\ the\\:\\ 0\\.07791837522870029\ \(0\)\
\-\ region\\:\\ 0\\.07785929262494448\ \(0\)\
\-\ include\\:\\ 0\\.0774474603252196\ \(0\)\
\-\ however\\:\\ 0\\.07704292922571393\ \(0\)\
\-\ months\\:\\ 0\\.07576702109123634\ \(0\)\
\-\ if\\:\\ 0\\.07562955902528956\ \(0\)\
\-\ enhancement\\:\\ 0\\.07492116316732496\ \(0\)\
\-\ low\\:\\ 0\\.07468983542573743\ \(0\)\
\-\ soft\\:\\ 0\\.0692974970169919\ \(0\)\
\-\ imaging\\:\\ 0\\.06840652808031933\ \(0\)\
\-\ other\\:\\ 0\\.06759718486652763\ \(0\)\
\-\ posterior\\:\\ 0\\.06730985304559714\ \(0\)\
\-\ were\\:\\ 0\\.06709670390316964\ \(0\)\
\-\ large\\:\\ 0\\.0652195225107273\ \(0\)\
\-\ in\\:\\ 0\\.06476204858112689\ \(0\)\
\-\ presents\\:\\ 0\\.06261646417749035\ \(0\)\
\-\ that\\:\\ 0\\.05648707170892669\ \(0\)\
\-\ be\\:\\ 0\\.05280305750918105\ \(0\)\
\-\ at\\:\\ 0\\.049165266972507185\ \(0\)\
\-\ was\\:\\ 0\\.04536406673252923\ \(0\)\
\-\ patient\\:\\ 0\\.042336397217860436\ \(0\)\
\-\ for\\:\\ 0\\.039452252155894686\ \(0\)\
\-\ and\\:\\ 0\\.026897167017518663\ \(0\)\
\-\ of\\:\\ 0\\.025472869082961522\ \(0\)\
